<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">kpccz</journal-id><journal-title-group><journal-title xml:lang="ru">Комплексные проблемы сердечно-сосудистых заболеваний</journal-title><trans-title-group xml:lang="en"><trans-title>Complex Issues of Cardiovascular Diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2306-1278</issn><issn pub-type="epub">2587-9537</issn><publisher><publisher-name>Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17802/2306-1278-2025-14-6-6-14</article-id><article-id custom-type="elpub" pub-id-type="custom">kpccz-1785</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ. Кардиология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL STUDIES. Cardiology</subject></subj-group></article-categories><title-group><article-title>СОБЛЮДЕНИЕ КРИТЕРИЕВ ОЦЕНКИ КАЧЕСТВА ПРИ ВЕДЕНИИ ПАЦИЕНТОВ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ НА АМБУЛАТОРНОМ ЭТАПЕ</article-title><trans-title-group xml:lang="en"><trans-title>COMPLIANCE WITH QUALITY ASSESSMENT CRITERIA FOR PATIENTS WITH ATRIAL FIBRILLATION AT THE OUTPATIENT STAGE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4688-0739</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ефремушкина</surname><given-names>Анна Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Efremushkina</surname><given-names>Anna A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор профессор кафедры терапии и общей врачебной практики с курсом дополнительного медицинского образования федерального государственного бюджетного образовательного учреждения высшего образования «Алтайский государственный медицинский университет» Министерства здравоохранения Российской Федерации, Барнаул, Российская Федерация</p></bio><bio xml:lang="en"><p>PhD, Professor, Professor of the Department of Therapy and General Medical Practice with a course of additional medical education at the Federal State Budgetary Educational Institution of Higher Education “Altai State Medical University” of the Ministry of Health of the Russian Federation, Barnaul, Russian Federation</p></bio><email xlink:type="simple">sunsun3@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-6783-7829</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мальчёнкова</surname><given-names>Анастасия Олеговна</given-names></name><name name-style="western" xml:lang="en"><surname>Malchenkova</surname><given-names>Anastasia O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-кардиолог диспансерного отделения краевого государственного бюджетного учреждения здравоохранения «Алтайский краевой кардиологический диспансер», Барнаул, Российская Федерация</p></bio><bio xml:lang="en"><p>Cardiologist of the Dispensary Department, Regional State Budgetary Healthcare Institution “Altai Regional Cardiological Dispensary”, Barnaul, Russian Federation</p></bio><email xlink:type="simple">a_k_a_47_92@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Алтайский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Educational Institution of Higher Education “Altai State Medical University” of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Краевое государственное бюджетное учреждение здравоохранения «Алтайский краевой кардиологический диспансер»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Regional State Budgetary Healthcare Institution “Altai Regional Cardiological Dispensary”</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2025</year></pub-date><volume>14</volume><issue>6</issue><fpage>6</fpage><lpage>14</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ефремушкина А.А., Мальчёнкова А.О., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Ефремушкина А.А., Мальчёнкова А.О.</copyright-holder><copyright-holder xml:lang="en">Efremushkina A.A., Malchenkova A.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nii-kpssz.com/jour/article/view/1785">https://www.nii-kpssz.com/jour/article/view/1785</self-uri><abstract><sec><title>Основные положения</title><p>Основные положения</p><p>Впервые проанализировано выполнение критериев оценки качества ведения пациентов с фибрилляцией предсердий на амбулаторном этапе (согласно клиническим рекомендациям Министерства здравоохранения Российской Федерации 2020 г.) и их влияние на конечные точки через год наблюдения. В среднем у 50% пациентов соблюдается не менее 5 из 13 возможных критериев. Гипотеза о предикторности критериев качества в отношении однолетних исходов не подтвердилась по конечным точкам (частота вызовов скорой медицинской помощи, госпитализации и смерть вследствие сердечно-сосудистых заболеваний, транзиторные ишемические атаки и смерть от всех причин. При соблюдении не более 5 критериев качества госпитализации в течение года наблюдения происходили статистически значимо чаще.</p></sec><sec><title> </title><p> </p></sec><sec><title>Цель</title><p>Цель. Изучить клинико-функциональные характеристики пациентов с фибрилляцией предсердий (ФП), наблюдающихся в первичном звене здравоохранения; оценить эффективность диспансерного наблюдения больных ФП на амбулаторном этапе через год по таким конечным точкам, как частота вызовов скорой медицинской помощи (СМП), госпитализации вследствие сердечно-сосудистых заболеваний (ССЗ), смерть от ССЗ, смерть от других причин, в зависимости от соблюдения критериев оценки качества.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование включены 108 пациентов с неклапанной ФП. Всем пациентам проведены общеклиническое обследование, оценка соблюдения критериев качества медицинской помощи, выбор стратегии контроля ритма или частоты сердечных сокращений, коррекция терапии, обучение с рекомендациями для дальнейшего наблюдения. После года диспансерного наблюдения пациенты были приглашены на прием к кардиологу. В информационной системе за год были собраны сведения о впервые диагностированных заболеваниях, вызовах СМП, госпитализациях по поводу ССЗ, частоте транзиторных ишемических атак, смертях и их причинах.</p></sec><sec><title>Результаты</title><p>Результаты. Представлена комплексная характеристика пациентов с ФП, включающая клинико-функциональные и инструментальные данные, частоту соблюдения критериев качества медицинской помощи в соответствии с нормативными документами. Из 13 оцененных критериев у половины пациентов на амбулаторном этапе было выполнено не менее 5. Проверена гипотеза о возможности использования данных критериев как предикторов исходов через год наблюдения. По результатам анализа частоты развития конечных точек в группах с соблюдением и несоблюдением критериев качества статистически значимых различий не выявлено: частота вызовов СМП (p = 0,967), госпитализации вследствие ССЗ (р = 0,725), смерть от ССЗ (p = 0,179), развитие транзиторной ишемической атаки (p = 0,383), смерть от всех причин (p = 0,220). При соблюдении не более 5 критериев оценки качества ведения больных статистически значимо чаще наблюдались госпитализации в течение последующего года (р = 0,015).</p></sec><sec><title>Заключение</title><p>Заключение. В среднем соблюдается не менее 5 критериев оценки качества ведения больных ФП в соответствии с клиническими рекомендациями. При анализе конечных точек статистически значимой связи с количеством учтенных критериев качества не определено. Пациентов с ФП, у которых амбулаторно учтено не более 5 критериев, чаще госпитализируют по поводу ССЗ в течение года наблюдения.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Highlights</title><p>Highlights</p><p>For the first time, the fulfillment of criteria for assessing the quality of management of patients with atrial fibrillation at the outpatient stage and their contribution to the impact on the endpoints after a year of follow-up was analyzed. On average, at least 5 quality criteria are met in more than 50% of patients. The hypothesis of the predictor of CC for outcomes after one year has not been confirmed by endpoints (emergency calls p = 0.967; death from CVD p = 0.179; TIA p = 0.383; all deaths p = 0.220). The possibility of using 6 quality criteria as a diagnostic feature in the presence of paroxysmal AF with a sensitivity of 93.3 was found %; the specificity is 39.7%.</p></sec><sec><title> </title><p> </p></sec><sec><title>Aim</title><p>Aim. To study the clinical and functional characteristics of patients with AF followed in primary healthcare, and to assess the effectiveness of DO for patients with AF after one year of outpatient follow-up based on endpoints such as the frequency of EMS calls, CVD hospitalizations, CVD death, and death from other causes, depending on adherence to QC.</p></sec><sec><title>Methods</title><p>Methods. The study included 108 patients with non-valvular AF. All patients underwent a general clinical examination, assessment of adherence to QC, selection of a heart rate (HR) control strategy, therapy adjustment, patient education, and recommendations for further follow-up. After one year of DO, the patient was invited for a follow-up appointment with a cardiologist. Over the year, data on newly diagnosed diseases, EMS calls, hospitalizations due to CVD, frequency of TIA, deaths and their causes were collected in the information system.</p></sec><sec><title>Results</title><p>Results. A comprehensive characterization of patients with AF is presented, including clinical, functional, and instrumental characteristics, and the frequency of adherence to QC according to regulatory documents. Out of 13 assessed QC at the outpatient stage, 5 were met in 50% of patients, and more than 5 QC were met in 50% of patients. The hypothesis about the possibility of using QC as predictors of outcomes after 1 year of follow-up (such as EMS calls, CVD hospitalizations, CVD deaths, and others) was tested. This hypothesis was not confirmed. According to the results of the analysis of the frequency of endpoint development in the groups with and without compliance with the CC, no significant differences were found the results for endpoints were as follows: frequency of EMS calls (p = 0.967), CVD hospitalizations (p = 0.725), CVD death (p = 0.179), development of TIA (p = 0.383), all-cause mortality (p = 0.220). In the group of patients with adherence to 5 or fewer QC, hospitalizations during the subsequent year were statistically significantly more frequent (p = 0.015).</p></sec><sec><title>Conclusion</title><p>Conclusion. On average, no fewer than 5 QC are met. When assessing endpoints, no statistically significant association with the number of QC is observed. Patients with AF for whom 5 or fewer QC were met on an outpatient basis are hospitalized due to CVD more often during the one-year follow-up period</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>Фибрилляция предсердий</kwd><kwd>Критерии оценки качества</kwd><kwd>Амбулаторный этап</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Atrial fibrillation</kwd><kwd>Quality criteria</kwd><kwd>Outpatient stage</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Авторы заявляют об отсутствии финансирования исследования.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Канорский С.Г., Галенко-Ярошевский П. А., Алексеенко С.Н., Голицын С.П. Фибрилляция предсердий: вчера, сегодня, завтра. Кубанский научный медицинский вестник. 2025;32(3): 107-120. doi.org/10.25207/1608-6228-2Q25-32-3-107-120</mixed-citation><mixed-citation xml:lang="en">Kanorskiy S.G., Galenko-Yaroshevsky P. A., Alekseenko S.N., Golitsyn S.P. Atrial fibrillation: yesterday, today, tomorrow. Kuban Scientific Medical Bulletin. 2025;32(3): 107-120. doi.org/10.25207/1608-6228-2Q25-32-3-107-120 (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ю. В. Мареев, Д. С. Поляков, Н. Г. Виноградова, И. В. Фомин, В. Ю. Мареев, Ю. Н. Беленков, Ф. Т. Агеев, Е. Г. Артемьева, Ю. В. Бадин, Е. В. Бакулина, А. С. Галявич, Т. С. Ионова, Г. М. Камалов, С. Г. Кечеджиева, Н. А. Козиолова, В. Ю. Маленкова, С. В. Мальчикова, Е. А. Смирнова, Е. И. Тарловская, Е. В. Щербинина, С. С. Якушин. ЭПОХА: Эпидемиология фибрилляции предсердий в репрезентативной выборке Европейской части Российской Федерации. 022 Apr 30;62(4):12-19. doi: 10.18087/cardio.2022.4.n1997</mixed-citation><mixed-citation xml:lang="en">Yu. V. Mareev, D. S. Polyakov, N. G. Vinogradova, I. V. Fomin, V. Yu. Mareev, Yu. N. Belenkov, F. T. Ageev, E. G. Artemyeva, Yu. V. Baden, E. V. Bakulina, A. S. Galyavich, T. S. Ionova, G. M. Kamalov, S. G. Kechedzhieva, N. A. Koziolova, V. Y. Malenkova, S. V. Malchikova, E. A. Smirnova, E. I. Tarlovskaya, E. V. Shcherbinina, S. S. Yakushin. EPOCH: Epidemiology of atrial fibrillation in a representative sample of the European part of the Russian Federation. 022 Apr 30;62(4):12-19. doi: 10.18087/cardio.2022.4.n1997 (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">M. A. Shkolnikova, D. A. Jdanov, R. A. Ildarova et al. Atrial fibrillation among Russian men and women aged 55 years and older: prevalence, mortality, and associations with biomarkers in a population-based study / J. Geriatr. Cardiol. – 2020. – N. 2. – V. 17. – P. 74-84. – doi: 10.11909/j.issn.1671-5411.2020.02.002.</mixed-citation><mixed-citation xml:lang="en">M. A. Shkolnikova, D. A. Jdanov, R. A. Ildarova et al. Atrial fibrillation among Russian men and women aged 55 years and older: prevalence, mortality, and associations with biomarkers in a population-based study / J. Geriatr. Cardiol. – 2020. – N. 2. – V. 17. – P. 74-84. – doi: 11/10/1909/j.issn.1671-5411.2020.02.002.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Беленков Ю.Н. Попова Л.В., Ильгисонис И.С. Тактика ведения пациентов с фибрилляцией предсердий и малыми кровотечениями в условиях терапии прямыми пероральными антикоагулянтами. Кардиология. 2021;61(12):72–81</mixed-citation><mixed-citation xml:lang="en">Belenkov Yu.N. Popova L.V., Ilgisonis I.S. Tactics of management of patients with atrial fibrillation and minor bleeding during therapy with direct oral anticoagulants. Cardiology. 2021;61(12):72–81 (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Spertus J , Dorian P , Bubien R , et al. Development and validation of the Atrial Fibrillation Ew ect on QualiTy-of-Life (AFEQT) questionnairein patients with atrial fibrillation. Circ Arrhythm Electrophysiol 2011;4:15–25.Van Gelder IC, Groenveld HF, Crijns HJ et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010;362:1363–1373</mixed-citation><mixed-citation xml:lang="en">Spertus J , Dorian P , Bubien R , et al. Development and validation of the Atrial Fibrillation Ew ect on QualiTy-of-Life (AFEQT) questionnairein patients with atrial fibrillation. Circ Arrhythm Electrophysiol 2011;4:15–25.Van Gelder IC, Groenveld HF, Crijns HJ et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010;362:1363–1373</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chao TF , Lip GYH , Lin YJ , et al. Incident risk factors and major bleeding in patients with atrial fibrillation treated with oral anticoagulants: a comparison of baseline, follow-up and delta HAS BLED scores with an approach focused on modifiable bleeding risk factors. Thromb Haemost 2018;118:768–777.</mixed-citation><mixed-citation xml:lang="en">Chao TF , Lip GYH , Lin YJ , et al. Incident risk factors and major bleeding in patients with atrial fibrillation treated with oral anticoagulants: a comparison of baseline, follow-up and delta HAS BLED scores with an approach focused on modifiable bleeding risk factors. Thromb Haemost 2018;118:768–777.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">William H Seligman, Zofia Das-Gupta, Adedayo O Jobi-Odeneye, Elena Arbelo, Amitava Banerjee, Andreas Bollmann, Bridget Caffrey-Armstrong, Daniel A Cehic, Ramon Corbalan, Michael Collins, Gopi Dandamudi, Prabhakaran Dorairaj, Matthew Fay, Isabelle C Van Gelder, Shinya Goto, Christopher B Granger, Bathory Gyorgy, Jeff S Healey, Jeroen M Hendriks, Mellanie True Hills, F D Richard Hobbs, Menno V Huisman, Kate E Koplan, Deirdre A Lane, William R Lewis, Trudie Lobban, Benjamin A Steinberg, Christopher J McLeod, Spencer Moseley, Adam Timmis, Guo Yutao, A John Camm, Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group, European Heart Journal, Volume 41, Issue 10, 7 March 2020, Pages 1132–1140, doi.org/10.1093/eurheartj/ehz871</mixed-citation><mixed-citation xml:lang="en">William H Seligman, Zofia Das-Gupta, Adedayo O Jobi-Odeneye, Elena Arbelo, Amitava Banerjee, Andreas Bollmann, Bridget Caffrey-Armstrong, Daniel A Cehic, Ramon Corbalan, Michael Collins, Gopi Dandamudi, Prabhakaran Dorairaj, Matthew Fay, Isabelle C Van Gelder, Shinya Goto, Christopher B Granger, Bathory Gyorgy, Jeff S Healey, Jeroen M Hendriks, Mellanie True Hills, F D Richard Hobbs, Menno V Huisman, Kate E Koplan, Deirdre A Lane, William R Lewis, Trudie Lobban, Benjamin A Steinberg, Christopher J McLeod, Spencer Moseley, Adam Timmis, Guo Yutao, A John Camm, Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group, European Heart Journal, Volume 41, Issue 10, 7 March 2020, Pages 1132–1140, doi.org/10.1093/eurheartj/ehz871</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lau DH , Nattel S , Kalman JM , Sanders P. Modifiable risk factors and atrial fibrillation. Circulation 2017;136:583–596.</mixed-citation><mixed-citation xml:lang="en">Lau DH , Nattel S , Kalman JM , Sanders P. Modifiable risk factors and atrial fibrillation. Circulation 2017;136:583–596.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">William H Seligman, Zofia Das-Gupta, Adedayo O Jobi-Odeneye, Elena Arbelo, Amitava Banerjee, Andreas Bollmann, Bridget Caffrey-Armstrong, Daniel A Cehic, Ramon Corbalan, Michael Collins, Gopi Dandamudi, Prabhakaran Dorairaj, Matthew Fay, Isabelle C Van Gelder, Shinya Goto, Christopher B Granger, Bathory Gyorgy, Jeff S Healey, Jeroen M Hendriks, Mellanie True Hills, F D Richard Hobbs, Menno V Huisman, Kate E Koplan, Deirdre A Lane, William R Lewis, Trudie Lobban, Benjamin A Steinberg, Christopher J McLeod, Spencer Moseley, Adam Timmis, Guo Yutao, A John Camm, Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group, European Heart Journal, Volume 41, Issue 10, 7 March 2020, Pages 1132–1140, doi:10.1093/eurheartj/ehz871</mixed-citation><mixed-citation xml:lang="en">William H Seligman, Zofia Das-Gupta, Adedayo O Jobi-Odeneye, Elena Arbelo, Amitava Banerjee, Andreas Bollmann, Bridget Caffrey-Armstrong, Daniel A Cehic, Ramon Corbalan, Michael Collins, Gopi Dandamudi, Prabhakaran Dorairaj, Matthew Fay, Isabelle C Van Gelder, Shinya Goto, Christopher B Granger, Bathory Gyorgy, Jeff S Healey, Jeroen M Hendriks, Mellanie True Hills, F D Richard Hobbs, Menno V Huisman, Kate E Koplan, Deirdre A Lane, William R Lewis, Trudie Lobban, Benjamin A Steinberg, Christopher J McLeod, Spencer Moseley, Adam Timmis, Guo Yutao, A John Camm, Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group, European Heart Journal, Volume 41, Issue 10, 7 March 2020, Pages 1132–1140, doi:10.1093/eurheartj/ehz871</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Министерство здравоохранения Российской федерации. Клинические рекомендации «Фибрилляция и трепетание предсердий» от 26.09.2025г. Available: https://cr.minzdrav.gov.ru/preview-cr/382_2</mixed-citation><mixed-citation xml:lang="en">Ministry of Health of the Russian Federation. Clinical recommendations "Atrial fibrillation and flutter" dated 09/26/2025. Available: https://cr.minzdrav.gov.ru/preview-cr/382_.2 (in Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
